Overview


According to FutureWise analysis the market for dialysis is expected to reach US$ 149.8 billion by 2031 at a CAGR of 4.90%.

Dialysis is used for filtering blood to balance the fluid and electrolyte levels in patients diagnosed with kidney dysfunction. This method has to be used when the kidneys are functioning less than 10 percent of normal. Dialysis is required during end-stage renal disease treatment and during kidney transplant. Periodontal dialysis and haemodialysis are two primary types of dialysis that enable waste eradication and removal of excessive water from the blood. In haemodialysis, waste products like urea are eradicated from the blood while the peritoneal dialysis uses the peritoneum of the abdomen for dialysis.

There has been a substantial rise in the number of patients diagnosed with kidney dysfunction. According to the National Kidney Foundation, in 2014, over 2 million people worldwide were diagnosed with chronic kidney failure and are undergoing dialysis currently. Such a rise in the number of kidney patients has propelled the dialysis market growth.

  • Fresenius Medical Care AGCo. KGaA
  • B. Braun
  • NIPRO Medical Corporation
  • DaVita Inc.
  • Baxter
  • Asahi Kasei Corporation
  • Kawasumi Laboratories
  • Medtronic
  • Nikkiso Co., Ltd
  • U.S. Renal Care.
  • Toray Industries
  • Satellite Healthcare

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Hemodialysis
  • Peritoneal Dialysis

By Product and service

  • Equipment
    • Dialysis Machines
    • Water Treatment Systems
    • Other Equipments
  • Consumables
    • Dialyzers
    • Catheters
    • Access products
    • Concentrates
    • Other Consumables
  • Services

By End User

  • Hospital-Based Dialysis
  • Home-Based Dialysis

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

The market is categorised into type, product, end user and region. The type segment is classified into haemodialysis and peritoneal dialysis. The haemodialysis segment is further divided into conventional dialysis, nocturnal haemodialysis and short daily haemodialysis while the peritoneal dialysis segment is bifurcated into continuous ambulatory peritoneal dialysis and automated peritoneal dialysis. The peritoneal dialysis segment is predicted to hold the largest dialysis market share, and this can be due to the increased insistence for peritoneal dialysis, especially amongst children and infants. Furthermore, this method has a wide range of applications, particularly in home-based services. For instance, Baxter Inc., in April 2015, were awarded with a CE approval for launching Homechoice Claria in Europe. This device can perform peritoneal dialysis in home-based settings. The product segment is fragmented into device, consumables and services. The devices segment is further bifurcated into dialysers, water treatment systems, dialysis machines and others while consumables segment is further divided into concentrates, catheters, bloodline and others. The end user segment is classified into hospital-based and home-based dialysis. The home-based dialysis segment is anticipated to grow at a significant rate during the forecast period owing to the rising demand for home-based medical services and the rising geriatric population. The hospital-based segment, on the other hand, currently dominates the market and this is backed up by data provided by Global Dialysis which states that over 16,000 centres were set in over 160 countries in 2015. Furthermore, many key players have collaborated with major hospital chains to set up hospital-based dialysis. For example, in 2017, Fresenius Medical Care Co. collaborated with John Hopkins Hospitals in setting up over eight centres in Baltimore, U.S, owing to the rising demand for this service in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global dialysis market By Type, By Product and Service, By End User and by Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Dialysis Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Dialysis Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Dialysis Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Dialysis Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hemodialysis
        2. Peritoneal Dialysis

  • 8.   Dialysis Market, By Product and Service Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Equipment
         1.1. Dialysis Machines
         1.2. Water Treatment Systems
         1.3. Other Equipments
        2. Consumables
         2.1. Dialyzers
         2.2. Catheters
         2.3. Access products
         2.4. Concentrates
         2.5. Other Consumables
        3. Services

  • 9.   Dialysis Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospital-Based Dialysis
        2. Home-Based Dialysis

  • 10.   North America Dialysis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Dialysis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Dialysis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Dialysis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Fresenius Medical Care AGCo. KGaA
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. B. Braun
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. NIPRO Medical Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. DaVita Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Baxter
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Asahi Kasei Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Kawasumi Laboratories
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Medtronic
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Nikkiso Co., Ltd
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. U.S. Renal Care.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Toray Industries
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Satellite Healthcare
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11